EuropaBio is Europe's largest and most influential biotech industry group, whose members include Monsanto, Bayer and other biotechnology companies. The organisation was initiated in 1996 to represent the interests of the biotechnology industry at European level and therefore influence legislation that serves the interests of biotechnology companies in Europe.
Activity and goals
EuropaBio is engaged in dialogue with the European Parliament, the European Commission, and the Council of Ministers to influence legislation on biotechnology. EuropaBio represents the three traditional sectors of the biotech industry.
Red or healthcare biotechnology is the application of biotechnology for the production of medicines and therapies.
Green or agrifood biotechnology is a collection of technologies using plant organisms and plant cells for the production or transformation of food, biomaterials and energy.
EuropaBio's stated goals are to:
promote an innovative, coherent and dynamic biotechnology-based industry in Europe
advocate free and open markets and the removal of barriers to competitiveness with other areas of the world
commit to an open, transparent and informed dialogue with all stakeholders about the ethical, social, and economic aspects of biotechnology and its benefits
champion the socially responsible use of biotechnology to ensure that its potential is fully used to the benefit of humans and their environment
EuropaBio's primary focus is the European Union but because of the global character of the biotech business, it also represents its members in transatlantic and worldwide forums.
EuropaBio believes there is "an urgent need to reshape the terms of the debate about GM in Europe." In an effort to transform European policy relating to the production and distribution of genetically modified foods within the EU, EuropaBio has proposed the creation of an "outreach program." This entails recruiting high-profile "ambassadors" in an effort to sway opinion on GM policy by lobbying European leaders directly. A public relations company working for EuropaBio claimed that a number of well known public figures had expressed interest in the ambassadorial positions. EuropaBio intends to introduce the ambassadors to high-level European bureaucrats and MEPs in with the goal of making a stronger case for GM within EU institutions.
Organisation
EuropaBio has a board of management made up of representatives from among its industry members. Since June 2018, Tjerk de Ruiter Corbion is Chairman of the Board. The Board is assisted by sectoral councils representing the main segments of EuropaBio - healthcare, industrial, and agriculture. Experts from member companies and national associations participate in EuropaBio's working groups which cover a very wide range of issues and areas of concern of biotech enterprises. Since September 2018 EuropaBio Secretary General is Joanna Dupont-Inglis.
Members
In 2018, the association represents 78 corporate and associate members and BioRegions and 15 national biotechnology associations. Through the national associations, EuropaBio represents 1800 small and medium-sized enterprises.
